Cargando…

Obesity, hypertension, and chronic kidney disease

Obesity is a major risk factor for essential hypertension, diabetes, and other comorbid conditions that contribute to development of chronic kidney disease. Obesity raises blood pressure by increasing renal tubular sodium reabsorption, impairing pressure natriuresis, and causing volume expansion via...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hall, Michael E, do Carmo, Jussara M, da Silva, Alexandre A, Juncos, Luis A, Wang, Zhen, Hall, John E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933708/ https://www.ncbi.nlm.nih.gov/pubmed/24600241 http://dx.doi.org/10.2147/IJNRD.S39739

Ejemplares similares

Interaction of Obesity and Hypertension on Cardiac Metabolic Remodeling and Survival Following Myocardial Infarction
por: Mouton, Alan J., et al.
Publicado: (2021)

Transient receptor potential cation channel 6 contributes to kidney injury induced by diabetes and hypertension
por: Wang, Zhen, et al.
Publicado: (2022)

Leptin reverses hyperglycemia and hyperphagia in insulin deficient diabetic rats by pituitary-independent central nervous system actions
por: da Silva, Alexandre A., et al.
Publicado: (2017)

A Functional Melanocortin System May Be Required for Chronic CNS-Mediated Antidiabetic and Cardiovascular Actions of Leptin
por: da Silva, Alexandre A., et al.
Publicado: (2009)

Cigarette Smoking and Chronic Kidney Disease in African Americans in the Jackson Heart Study
por: Hall, Michael E., et al.
Publicado: (2016)

Targeting immunometabolism during cardiorenal injury: roles of conventional and alternative macrophage metabolic fuels
por: Mouton, Alan J., et al.
Publicado: (2023)

Direct Cardiac Actions of Sodium-Glucose Cotransporter 2 Inhibition Improve Mitochondrial Function and Attenuate Oxidative Stress in Pressure Overload-Induced Heart Failure
por: Li, Xuan, et al.
Publicado: (2022)

Impact of leptin deficiency on male tibia and vertebral body 3D bone architecture independent of changes in body weight
por: Williamson, Alexander, et al.
Publicado: (2023)

Direct Cardiac Actions of the Sodium Glucose Co‐Transporter 2 Inhibitor Empagliflozin Improve Myocardial Oxidative Phosphorylation and Attenuate Pressure‐Overload Heart Failure
por: Li, Xuan, et al.
Publicado: (2021)

BOLD magnetic resonance imaging in nephrology
por: Hall, Michael E, et al.
Publicado: (2018)

Role of Shp2 in forebrain neurons in regulating metabolic and cardiovascular functions and responses to leptin
por: do Carmo, Jussara M., et al.
Publicado: (2013)

Chronic Kidney Disease, Obesity, and Hypertension: The Role of Leptin and Adiponectin
por: Tesauro, M., et al.
Publicado: (2012)

Reproducibility in Research: The Role of Kidney360
por: Allon, Michael, et al.
Publicado: (2023)

Autophagy Function and Regulation in Kidney Disease
por: Kaushal, Gur P., et al.
Publicado: (2020)

Molecular Interactions Between Reactive Oxygen Species and Autophagy in Kidney Disease
por: Kaushal, Gur P., et al.
Publicado: (2019)

Chronic HO-1 Induction with Cobalt Protoporphyrin (CoPP) Treatment Increases Oxygen Consumption, Activity, Heat Production and Lowers Body Weight in Obese Melanocortin-4 Receptor Deficient Mice
por: Csongradi, Eva, et al.
Publicado: (2011)

Obesity-related hypertension and chronic kidney disease: from evaluation to management
por: Jung, Mi-Hyang, et al.
Publicado: (2023)

Central Nervous System Actions of Leptin Improve Cardiac Function After Ischemia–Reperfusion: Roles of Sympathetic Innervation and Sex Differences
por: Omoto, Ana C. M., et al.
Publicado: (2022)

The Modulatory Role of Heme Oxygenase on Subpressor Angiotensin II-Induced Hypertension and Renal Injury
por: Chandrashekar, Kiran, et al.
Publicado: (2012)

In search for potential antidiabetic compounds from natural sources: docking, synthesis and biological screening of small molecules from Lycium spp. (Goji)
por: Yalamanchili, Chinni, et al.
Publicado: (2019)

Do Uncontrolled Hypertension, Diabetes, Dyslipidemia, and Obesity Mediate the Relationship Between Health Literacy and Chronic Kidney Disease Complications?
por: Gurgel do Amaral, Matheus, et al.
Publicado: (2021)

The Association Between Inflammatory Markers and Hypertension. A Call for Anti-Inflammatory Strategies?
por: García, Néstor H., et al.
Publicado: (2006)

Prevalence of non-communicable chronic diseases: arterial hypertension, diabetes mellitus, and associated risk factors in long-lived elderly people
por: da Silva, Andreia Matos, et al.
Publicado: (2023)

Comparison of Serum Concentrations of Symmetric Dimethylarginine and Creatinine as Kidney Function Biomarkers in Cats with Chronic Kidney Disease
por: Hall, J.A., et al.
Publicado: (2014)

Restoration of Cardiac Function After Myocardial Infarction by Long-Term Activation of the CNS Leptin-Melanocortin System
por: Gava, Fabio N., et al.
Publicado: (2021)

Hypertension Management in Patients with Chronic Kidney Disease
por: Hebert, Sean A., et al.
Publicado: (2022)

Hypertension in Chronic Kidney Disease: Navigating the Evidence
por: Tedla, F. M., et al.
Publicado: (2011)

Hypertension and chronic kidney disease in Turkey
por: Sengul, Sule, et al.
Publicado: (2013)

Management of Hypertension in Chronic Kidney Disease
por: Pugh, Dan, et al.
Publicado: (2019)

Hypertension and obesity in living kidney donors
por: Mohamed, Mahmoud M, et al.
Publicado: (2021)

Changes in the Fecal Metabolome Are Associated with Feeding Fiber Not Health Status in Cats with Chronic Kidney Disease
por: Hall, Jean A., et al.
Publicado: (2020)

Experimental Pharmacology in Transgenic Rodent Models of Alzheimer’s Disease
por: Cuello, A. Claudio, et al.
Publicado: (2019)

Modeling the renoprotective mechanisms of SGLT2 inhibition in hypertensive chronic kidney disease
por: Clemmer, John S., et al.
Publicado: (2023)

Temporal changes in glucose metabolism reflect polarization in resident and monocyte-derived macrophages after myocardial infarction
por: Mouton, Alan J., et al.
Publicado: (2023)

Chronic Kidney Disease and Hypertension with Reference to COVID-19
por: Rathi, Manish, et al.
Publicado: (2020)

Resistant Hypertension in Nondialysis Chronic Kidney Disease
por: Borrelli, Silvio, et al.
Publicado: (2013)

Hypertension and Chronic Kidney Disease in Primary Care
por: Alexander, Alice
Publicado: (2016)

Correction to: Management of Hypertension in Chronic Kidney Disease
por: Pugh, Dan, et al.
Publicado: (2020)

Hypertension and chronic kidney disease in Asian populations
por: Teo, Boon Wee, et al.
Publicado: (2021)

Serum Concentrations of Symmetric Dimethylarginine and Creatinine in Dogs with Naturally Occurring Chronic Kidney Disease
por: Hall, J.A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r5t6a7lv4l17l5qumdapb8bes2